The FDA’s push to reclassify naloxone as an OTC product appears tepid and plodding. At a time when the nation is enduring a severe public health emergency - with record numbers of (illicit) opioid overdose-related deaths - it’s crucial that naloxone become available OTC as soon as possible.
Subscribe to:
Post Comments (Atom)
< + > Beyond the Rules Engine: How Agentic AI Is Helping Health Plans Solve Prior Authorization
The following is a guest article by Robert Laumeyer, Chief Technology Officer at Availity Healthcare automation has long been sold as a co...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
-
Robert Connely of Pega says patching legacy systems will give way to true health IT modernization, a security breakthrough will lead artific...
No comments:
Post a Comment